Cite
6009 POSTER Risk factors for early mortality, relapse and overall survival in new cases of APL treated by arsenic trioxide.
MLA
Alimoghaddam, K., et al. “6009 POSTER Risk Factors for Early Mortality, Relapse and Overall Survival in New Cases of APL Treated by Arsenic Trioxide.” EJC Supplements, vol. 5, no. 4, Aug. 2007, pp. 347–48. EBSCOhost, https://doi.org/10.1016/S1359-6349(07)71300-9.
APA
Alimoghaddam, K., Ghavamazadeh, A., Ghaffari, S. A., Rostami, S., Hosseini, R., Jahani, M., Bahar, B., Tootonchi, M., Mortazavi, Y., & Baybordi, E. (2007). 6009 POSTER Risk factors for early mortality, relapse and overall survival in new cases of APL treated by arsenic trioxide. EJC Supplements, 5(4), 347–348. https://doi.org/10.1016/S1359-6349(07)71300-9
Chicago
Alimoghaddam, K., A. Ghavamazadeh, S.A. Ghaffari, S. Rostami, R. Hosseini, M. Jahani, B. Bahar, M. Tootonchi, Y. Mortazavi, and E. Baybordi. 2007. “6009 POSTER Risk Factors for Early Mortality, Relapse and Overall Survival in New Cases of APL Treated by Arsenic Trioxide.” EJC Supplements 5 (4): 347–48. doi:10.1016/S1359-6349(07)71300-9.